Local News Amylyx Pharmaceuticals Announces AMX0035 Demonstrated Statistically Significant Treatment Benefit for People with ALS in the CENTAUR Trial Brigham and Women's Hospital | December 20, 2019 Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis…sciencecityDecember 20, 2019 Read More
Local News Helping to Uncover the Mechanism Controlling Brain States Harvard Gazette | December 20, 2019 It might be complicated, but the concept is as simple as a light switch. A…sciencecityDecember 20, 2019 Read More
Local News Study May Explain How Infections Reduce Autism Symptoms MIT News | December 20, 2019 For many years, some parents have noticed that their autistic children’s behavioral symptoms diminished when…sciencecityDecember 20, 2019 Read More
Local News Scipher Medicine Closes Series B Funding Led By Northpond Ventures BioSpace | December 20, 2019 Scipher Medicine, developer of a molecular technology platform used to ensure patients are prescribed the…sciencecityDecember 20, 2019 Read More
Local News Researchers Uncover Genetic Mystery of Infertility in Fruit Flies BU School of Medicine | December 20, 2019 Researchers have discovered a novel parasitic gene in fruit flies that is responsible for destroying…sciencecityDecember 20, 2019 Read More
Local News Platelet BioGenesis Receives $2.3 Million Award from the Medical Technology Enterprise Consortium to Accelerate Development of Donor-Independent Platelet Production BioSpace | December 19, 2019 Platelet Biogenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and genetically…sciencecityDecember 19, 2019 Read More
Local News Dana-Farber Research Supports New Indication for a Prostate Cancer Drug, Which Has Received FDA Approval Dana-Farber Cancer Institute | December 19, 2019 An oral androgen receptor inhibitor whose clinical testing in metastatic hormone-sensitive prostate cancer (mHSPC) was…sciencecityDecember 19, 2019 Read More
Local News Alnylam’s Lumasiran Sees Positive Results for Ultra-Rare Kidney Disease BioSpace | December 19, 2019 Cambridge, Massachusetts-based Alnylam Pharmaceuticals announced positive results from its ILLUMINATE-A Phase III trial. The study was investigating lumasiran,…sciencecityDecember 19, 2019 Read More
Local News Mass General Team Detects Alzheimer’s Early Using Electronic Health Records Mass General News | December 19, 2019 A team of scientists from Massachusetts General Hospital (MGH) has developed a software-based method of…sciencecityDecember 19, 2019 Read More
Local News In an About Face, FDA Approves Sarepta’s 2nd Duchenne Drug | December 18, 2019 The FDA unexpectedly reversed course Thursday, approving the second treatment developed by Sarepta Therapeutics for the rare…sciencecityDecember 18, 2019 Read More